Examining an Antioxidant Biostimulating Treatment for Dark, Postinflammatory Hyperpigmentation-Prone Skin

Skin rejuvenation treatments, including chemical peels and biostimulatory therapies, aim to improve facial aging concerns. However, these treatments have limitations, including efficacy, safety, postinflammatory hyperpigmentation in dark skin types, and downtime. An Antioxidant Biostimulating Treatment (ABT) is an innovative approach that integrates the principles of chemical peels and biostimulatory therapies to deliver superior benefits with traditional invasive and non-invasive therapies, while reducing the risk of adverse events. ABT utilizes a multi-acid delivery system to create controlled epidermal fissures, facilitating the safe delivery of phytocompound antioxidant acids into the dermis for skin rejuvenation. The safety and efficacy of the ABT were assessed in patients with Fitzpatrick Skin Types (FST) V-VI with mild to moderate global facial radiance, skin smoothness, and overall appearance. The ABT improved overall appearance, radiance, and skin smoothness after three sessions spaced 4 weeks apart. The ABT was well tolerated with no incidence of postinflammatory hyperpigmentation or other adverse events. The ABT addresses the critical need in offering patients safe, non-invasive, and comprehensive skin rejuvenation treatment options with demonstrated efficacy in all skin tones.